用重组纯化M_2抗原检测抗线粒体抗体M_2在原发性胆汁性肝硬化诊断中的意义
摘要
原发性胆汁性肝硬化(primary biliary cirrhosis,PBC)是一种由免疫介导的慢性进展性疾病,以血清自身抗体和肝内汇管区细胞浸润为特征,主要表现为肝内小胆管进行性破坏与门静脉炎症性改变。高滴度的抗线粒体抗体(anti-mitoc hondrial antibody,AMA)为PBC血清学诊断标志。
出处
《中国药物与临床》
CAS
2012年第2期177-179,共3页
Chinese Remedies & Clinics
参考文献10
-
1姜小华,仲人前,孔宪涛.原发性胆汁性肝硬化发病机制研究进展[J].中国免疫学杂志,2002,18(8):586-589. 被引量:19
-
2Koizumi H,Onozuka Y,Shibata M,et al.Positive rate of antimi-tochondrial antibody in Japanese corporate workers.Rinsho By-ori,2000,48(10):966-970.
-
3Homberg JC,Stelly N,Andreis I,et al.A new anti-mitochondrial antibody(anti-M6) in iproniazid-induced hepatitis.Clin Exp Immunol,1982,47:93-102.
-
4Miyakawa et al.Detection of antimitochondrial autoantibodies in immunofluorescent AMA-Negative patients with primary biliary cirrhosis using recombinant autoantigens.Hepatology,2001,34:243-248.
-
5Joplin RE,Neuberger JM.Immunopalhology of primary biliary cirrhosis.Eur J Gastroenterol,1999,10:587-593.
-
6Nakano T,lnoue K,H irohara J,et al.Long-term prognosis of primary biliary cirrhosis (PBC) in Japan and analysis of the factors of stage progression in asymptomatic PBC (a2PBC).Hepa-tol Rest2002,22(2):250-260.
-
7Miyakawa H,Tanaka A.Kikuchi K,et al.Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant au-toantigens.Hepatology,2001,34(2):243-248.
-
8Uddenfeldt P,Danielsson A,Forssell A,et al.Features of Sjfi-gren's syndrome in patients with primary biliary cirrhosis.J Intern Med,1991,230.443.
-
9Tsuneyama K,Vande-Water J,Yamazaki K,et al.Primary biliary cirrhosis an epithelitis:evidence of abnormal salivary gland im-munohistochemistry.Autoimmunity,1997,26:23.
-
10Lindgren S,Manthorpe R,Eriksson S.Autoimmune liver disease in patients with primary Sjogren's syndrome.J Hepatol,1994,20:354.
二级参考文献18
-
1[1]Tanaka A, Borchers A T, Ishibashi H et al. Genetic and familial consider ations of primary biliary cirrhosis [ J ]. Am J Gastroenterol, 2001; 96 ( 1 ): 8
-
2[2]Kim W R, Lindor K D, Locke G R et al. Epidemiology and natural history of primary biliary cirrhosis in a US community[J]. Gastroenterology, 2000; 119(6): 1631
-
3[3]Miyakawa H, Tanaka A, Kikuchi K et al. High sensitivity of a novel ELISA for anti-M2 in primary biliary cirrhosis[J]. Hepatology, 2001; 34 (2) :243
-
4[4]Joplin R E, Neuberger J. Immunopathology of primary biliary cirrhosis [J]. Eur J Gastroenterol Hepatol, 1999; 11 (6) :587
-
5[5]Metcalf J V,Mitchison H C,Palmer J et al. Natural history of early pri mary biliary cirrhosis[J]. Lancet, 1996;348(8): 1399
-
6[6]Koizumi H, Onozuka Y, Shibata M et al. Positive rate of anti-mitochondri al antibody in Japanese corporate workers[J]. Rinsho Byori, 2000; 48 (10) :966
-
7[7]Jones D E J, Palmer J M, Kirby J A et al. Experimental autoimmune cholangitis: a mouse model of immune-mediated cholangiopathy[J]. Liver, 2000;20( 1 ): 351
-
8[8]Ahmed A F, Ohtani H, Nio M et al. CD8+ T cells infiltrating into bile ducts in biliary atresia do not appear to function as cytotoxic T cells: a clinicopathological analysis[J] .J Pathol,2001; 193(3) :383
-
9[9]Harada K, Ozaki S, Gershwin M E et al. Enhanced apoptosis relates to bile duct loss in primary biliary cirrhosis [J]. Hepatology, 1997; 26 (6): 1399
-
10[10]Sekiya H, Komats T,lsono E et al. Decrease in the prevalence of IL-4producing CD4+ T cells in patients with advanced stage of primary biliarycirrhosis[J]. Am J Gastroenterol, 1999 ;94(12): 3589
共引文献18
-
1谢国强,张勇.Leber-LIA法检测诊断自身免疫性肝炎[J].实用医技杂志,2005,12(07B):1832-1834.
-
2杨婧,杨晋辉,尤丽英.自身免疫性肝病20例临床分析[J].昆明医学院学报,2005,26(3):83-88.
-
3张雪梅,杨应树.抗线粒体抗体-M_2在原发性胆汁性肝硬化诊断中的重要意义[J].临床肝胆病杂志,2006,22(1):59-60. 被引量:2
-
4陈燕,姚定康,周晔,朱烨,蒋廷旺,邓安梅,仲人前.采用重组侧链二氧酸脱氢酶复合物E_2亚单位检测M_2抗体及其临床意义[J].中华风湿病学杂志,2007,11(7):410-412. 被引量:1
-
5刘秋香,朴云峰.抗线粒体抗体M2亚型与原发性胆汁性肝硬化[J].临床肝胆病杂志,2008,24(2):142-144. 被引量:7
-
6陈俊飞,衣展华,曹济生.32例原发性胆汁性肝硬化临床分析[J].实用肝脏病杂志,2009,12(5):375-376. 被引量:1
-
7姜小华,傅青春,孙建文,单阁,李君,方晓云,代龙,仲人前.AMA-M2抗体阳性原发性胆汁性肝硬化患者的实验室指标特征分析[J].肝脏,2010,15(2):84-86. 被引量:6
-
8宋秀珍,公惠萍,王平,张国杰,王海香.3种方法检测抗线粒体抗体Ⅱ型的比较及临床意义[J].中国药物与临床,2011,11(3):352-354.
-
9张凤兰,齐国海,冯巧荣.抗M2型线粒体抗体阳性患者46例实验室指标分析及确诊[J].中国药物与临床,2012,12(9):1238-1239. 被引量:1
-
10邹麟,肖然,陈瀑.120例肝功能损伤患者线粒体抗体及其M2亚型检测结果分析[J].重庆医学,2013,42(17):1946-1948. 被引量:2
-
1邹红梅,吉恒东.成人Still病28例临床分析[J].中国现代医生,2009,47(31):146-147. 被引量:4
-
2何江,周郁,桂俊豪,余伍忠,刘丽,张宇红,仇东辉,周颖,张阳.血清HA、CG、C-Ⅳ联检对肝硬化的诊断价值[J].放射免疫学杂志,2005,18(4):269-271. 被引量:2
-
3刘芸,野谢青.慢性乙型肝炎病毒感染的处理[J].肝脏,2004,9(2):118-120. 被引量:3
-
4曾玲玲,周桂琴.药物性肝损害诊断标准及其临床应用[J].药物不良反应杂志,2011,13(1):17-20. 被引量:47
-
5颜文伟.精神障碍的客观诊断标志探索[J].上海精神医学,2005,17(4):251-255.
-
6张燕婷,熊旭东,王倩.中医药治疗肺动脉高压研究现状[J].中国中医急症,2012,21(9):1467-1468. 被引量:5
-
7鞠海兵.新诊断2型糖尿病患者短期胰岛素强化治疗后的药物选择[J].药品评价,2015,0(19):26-28. 被引量:4
-
8甄琴,彭永德.C反应蛋白与糖尿病及其心血管并发症的关系[J].世界临床药物,2010,31(2):69-73. 被引量:3
-
9汪飞,卢佩颖,娄国忠,竺军高.丹红注射液联合前列地尔治疗COPD肺动脉高压60例[J].浙江中医杂志,2015,50(7):545-545. 被引量:3
-
10李光伟.恢复β细胞受损的功能——2型糖尿病治疗中的新话题[J].中华内分泌代谢杂志,2014,30(6):453-455. 被引量:4